The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

  • LOG IN
  • BECOME A MEMBER
  • About Us
    • Our Team
      • Directors and Officers
      • Our Staff
      • Our Committees
    • Sponsors & Partners
  • Society meetings
    • Computational Antibody Discovery: State of the Art
      • Computational Antibody Discovery Symposium Participants
    • Harnessing Cytokines for Cancer Immunotherapy Symposium
    • Biopharmaceutical Informatics Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2024
      • 2022 Antibody Engineering & Therapeutics
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics US 2025 | December 14-17 | San Diego, CA
      • Scientific Advisors, Antibody Engineering & Therapeutics Europe
    • FOCIS Symposia
  • AIRR Community
    • AIRR Community News
    • AIRR Community Newsletter
    • AIRR Community Seminar Series
    • AIRR Community Meetings
      • Zooming into the Community III
      • AIRR Community Meeting VII – Learnings and Perspectives
      • AIRR Community Special Event 2023  – Zooming in to the Community II
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • On AIRR – An AIRR Community Podcast
    • AIRR Data Commons
    • AIRR-C Germline Database Resources
    • AIRR Community Publications
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-Committees
      • Communications Sub-Committee
      • Executive Sub-Committee
      • Inferred Allele Review Committee
      • Meetings Sub-Committee
      • Strategic Planning Sub-Committee
    • AIRR Community Webinar Series
    • AIRR Community Calendar
    • AIRR Community Resources
  • Members only
    • Login
    • Note to members
    • Member discount codes
    • 2025 Calendar of Events
    • James S. Huston Antibody Science Talent Award
      • 2025 James S. Huston Antibody Science Talent Award Recipient
      • 2024 James S. Huston Antibody Science Talent Award Recipient
      • 2023 James S. Huston Antibody Science Talent Award Recipient
      • 2022 James S. Huston Antibody Science Talent Award Recipient
      • 2021 James S. Huston Antibody Science Talent Award Recipient
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • Huston Award submission guidelines
    • Research Competitions
      • The Antibody Society’s Research Competition Winners
    • Science Writing Competition
      • Science Writing Competition Winners
    • Imaging Competition
      • Imaging Calendar Competition winners
        • The Antibody Society 2025 Calendar
        • The Antibody Society 2024 Calendar
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings in 2025
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody News Podcast
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars in 2025
    • The Antibody Series Lectures 2025
    • Antibody Discovery & Development
    • Adaptive Immune Receptor Repertoires
    • Antibodies to Watch
    • Commercializing Antibody Therapeutics
    • Antibody Validation
      • 4th International Antibody Validation Meeting, Sep 2023
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics
You are here: Home / Jobs / A new career opportunity from Aureka Biotechnologies, Inc.

A new career opportunity from Aureka Biotechnologies, Inc.

November 7, 2025 by Joshua Dorai

Aureka Biotechnologies is expanding its Antibody Therapeutics team!

Aureka Bio is seeking a Principal Scientist or Director to lead antibody discovery programs in immunology and metabolic diseases. This role offers an exciting opportunity to contribute to a fast-growing, AI-driven biotech advancing next-generation biologics.

Full Job Description

Role: Principal Scientist or Director, Antibody Therapeutics in Immunology and Metabolic Diseases

Location: Irvine, CA

Company Summary: 

Aureka Biotechnologies is an AI-driven biotech startup integrating high-throughput biology with generative AI to discover and develop antibody therapeutics with exceptional speed and quality. Through multiple pharma partnerships, our platform has been validated to deliver best-in-class, differentiated antibodies that are difficult to identify using traditional approaches.

Position Summary:

Aureka Bio is seeking a highly motivated, passionate, and detail-oriented Senior Scientist or Principal Scientist to join our Antibody Therapeutics team. This is an exciting opportunity to contribute to a fast-growing, AI-driven biotherapeutics company dedicated to rapidly generating next-generation biologics for Immunology & Inflammation (I&I) and metabolic diseases.

The successful candidate will have 6+ years of hands-on experience in protein engineering and immunoscreening techniques, with a strong track record in biotherapeutic discovery and development. This role will provide the opportunity to lead multiple discovery campaigns, advancing programs from concept through preclinical development in close collaboration with cross-functional teams, including bioassay, translational biology, and CMC.

This is a bench-facing, on-site position based in Irvine, CA, offering high visibility and impact within a dynamic and collaborative environment. The final title and level will be determined based on experience.

Key Responsibilities

  • Lead the design, discovery, and optimization of monoclonal, bispecific, and multispecific antibodies using display and screening platforms (B-cell cloning, phage, and yeast display).
  • Execute small- and large-scale antibody expression and purification using chromatography techniques and evaluate purity via SDS-PAGE, analytical SEC, and Western blot.
  • Perform high-throughput antibody screening assays, including binding kinetics, ligand blocking, and epitope binning, to rapidly identify and prioritize lead candidates.
  • Design and develop recombinant protein-based immunoassays to characterize therapeutic antibodies using biochemical and biophysical methods.
  • Co-lead biotherapeutic discovery campaigns and partner closely with in vitro and in vivo pharmacology teams to evaluate PK/PD, efficacy, and safety profiles.
  • Provide strategic and technical input on antibody design, developability, and candidate selection during early-stage development.
  • Interface with CROs and external collaborators to ensure high-quality data generation and timely project execution.
  • Present experimental results and program updates to project teams, senior management, and collaborators.
  • Maintain accurate experimental documentation in ELN and ensure compliance with best data practices.
  • Stay current with emerging literature and technologies relevant to antibody engineering and biologics discovery.

Professional Experience and Qualifications

  • PhD in Biochemistry, Biomedical Engineering, Molecular Biology, or related discipline with at least 6 years research experience working in a biotech or large pharma setting is a must.
  • Experience working in therapeutic antibody pipeline discovery, screening, antibody engineering and optimization is a must.
  • Expertise in designing and conducting in vitro protein-based assays using diverse biophysical and bioanalytical methods (e.g., SPR/BLI, ELISA, DLS, thermal stability, immunoassays) is a must.
  • Strong understanding of protein engineering, Fc modifications, and developability assessments is essential.
  • Ability to work independently and as part of a team in a fast-paced environment with strong analytical and problem-solving skills, with attention to detail is essential.
  • Experience with antibody screening databases and proficiency in data analysis/visualization software, such as Spotfire, Dotmatics, D360, etc. is a plus.
  • Demonstrated scientific innovation and productivity, as evidenced by patents and/or peer-reviewed publications.
  • Strong communication and interpersonal skills, with the ability to present complex data clearly to cross-functional teams, leadership and collaborators.
  • Self-motivated, collaborative, and enthusiastic about contributing to a multidisciplinary, early-stage biotech focused on breakthrough antibody therapeutics.

Compensation:

Competitive and commensurate with experience, including salary, equity, and benefits—aligned with the company’s long-term success.

Why join us:

  • Competitive compensation, comprehensive healthcare coverage, equity participation, family leave and paid time off
  • A dynamic early-stage work environment and highly interdisciplinary, talented team with a collaborative and innovation-driven culture.
  • Participation in an unprecedented opportunity to significantly impact the quality of life of patients by developing a targeted approach to delivering therapeutic molecules.

Professional growth opportunities through mentoring, training, immersion in cross-functional projects, and opportunities to learn and try new things.

Contact Alon Wellner, Chief Innovation Officer at alon@aurekabio.com to apply.

Filed Under: Jobs

Share this post

  • LinkedIn

mabs

mabs

The Official Journal of The Antibody Society

Career Center

Our Career Center is a premier resource to connect highly qualified talent with matching career opportunities. Visit for details on over 800 jobs!

AIRR Community

AIRR Community

The Adaptive Immune Receptor Repertoire Community is a research-driven group organizing around the use of high-throughput sequencing technologies to study antibody/B-cell and T-cell receptor repertoires.

Recent Posts

  • A new career opportunity from Aureka Biotechnologies, Inc. November 7, 2025
  • Announcing The Antibody Society’s 2025 James S. Huston Antibody Science Talent Award winner! October 15, 2025
  • Precision in Antibody Format Design – Webinar with Dotmatics & BioGlyph. October 6, 2025

Archives

Follow us online

  • Email
  • LinkedIn
  • Twitter
  • YouTube
  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners Old
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals